Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | RXRA | P19793 | 2/20 | 0.54 |
| ▸ | RXRB | P28702 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.47 |
| ▸ | CHKA | P35790 | 2/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.43 |
| ▸ | RELA | Q04206 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28887111 | 0.97 | CYP1A2 (0.57) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL23560521 | 0.97 | CYP1A2 (0.65) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL20081661 | 0.94 | CYP1A2 (0.60) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL31576795 | 0.94 | CYP1A2 (0.60) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL24780597 | 0.94 | CYP1A2 (0.60) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL1959308 | 0.94 | CYP1A2 (0.60) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL30972562 | 0.92 | RXRA (0.59) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL18419157 | 0.92 | CYP1A2 (0.65) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL16949645 | 0.92 | CYP1A2 (0.65) | CYP1A2RXRARXRBALDH1A1TSHR | |
| SCHEMBL20088882 | 0.92 | CYP1A2 (0.65) | CYP1A2RXRARXRBALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | claimed |
| CN-110612119-A | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | 西雅图儿童医院（DBA西雅图儿童研究所） | 2019-12-24 | — | — | CN | claimed |
| WO-2018148224-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | Seattle Children's Hospital (dba Seattle Children's Research Institute) (US) | 2018-08-16 | — | — | WO | claimed |
| US-7989194-B2 | PCB-degrading recombinant bacterium, product for the bioremediation and method of bioremediation | UNIVERSIDAD TECNICA FEDERICO SANTA MARIA (CL) | 2011-08-02 | — | — | US | claimed |
| EP-0968739-B1 | Method for decomposing halogenated aliphatic and aromatic compounds | CANON KK (JP) | 2010-06-16 | — | — | EP | claimed |
| US-20080318302-A1 | PCB-Degrading recombinant bacterium, product for the bioremediation and method of bioremediation | UNIVERSIDAD TECNICA FEDERICO SANTA MARIA (CL) | 2008-12-25 | — | — | US | claimed |
| CN-101068773-A | Melanin concentrating hormone antagonists | PROCTER & GAMBLE (US) | 2007-11-07 | — | — | CN | claimed |
| EP-1667958-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-14 | — | — | EP | claimed |
| WO-2005033063-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-14 | — | — | WO | claimed |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-07 | — | — | US | claimed |
| EP-1005881-B1 | Method and apparatus for decomposing halogenated aliphatic hydrocarbon compounds or aromatic compounds | CANON KK (JP) | 2005-01-19 | — | — | EP | claimed |
| US-6616815-B2 | Contacting under irradiation with light a medium containing at least one of a halogenated aliphatic hydrocarbon compound and an aromatic compound with functional water produced by electrolysis of water containing an electrolyte | CANON KABUSHIKI KAISHA (JP) | 2003-09-09 | — | — | US | claimed |
| US-20030164286-A1 | Apparatus for decomposing halogenated aliphatic hydrocarbon compounds or aromatic compounds | CANON KABUSHIKI KAISHA (JP) | 2003-09-04 | — | — | US | claimed |
| US-20020163135-A1 | METHOD FOR DECOMPOSING HALOGENATED ALIPHATIC HYDROCARBON COMPOUNDS OR AROMATIC COMPOUNDS, METHOD FOR CLEANING MEDIUM CONTAMINATED WITH AT LEAST ONE OF THESE COMPOUNDS, AND APPARATUS FOR THESE | CANON KABUSHIKI KAISHA (JP) | 2002-11-07 | — | — | US | claimed |
| US-20020130030-A1 | METHOD OF DECOMPOSING HALOGENATED ALIPHATIC HYDROCARBON COMPOUNDS OR AROMATIC COMPOUNDS AND APPARATUS TO BE USED FOR THE SAME AS WELL AS METHOD OF CLARIFYING EXHAUST GAS AND APPARATUS TO BE USED FOR THE SAME | CANON KABUSHIKI KAISHA (JP) | 2002-09-19 | — | — | US | claimed |
| EP-1005881-A1 | Method and apparatus for decomposing halogenated aliphatic hydrocarbon compounds or aromatic compounds | CANON KABUSHIKI KAISHA (JP) | 2000-06-07 | — | — | EP | claimed |
| EP-0968739-A1 | Method and apparatus for decomposing halogenated aliphatic and aromatic compounds | CANON KABUSHIKI KAISHA (JP) | 2000-01-05 | — | — | EP | claimed |
| EP-4686757-A1 | INHIBITORS OF EXPRESSION AND/OR FUNCTION | e-therapeutics PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| US-4276179-A | Removing halogenated hydrocarbons from aqueous media by utilizing a polyolefinic microporous adsorbent | CELANESE CORPORATION (US) | 1981-06-30 | — | — | US | disclosed |
| US-4246255-A | Disposal of PCB | ROCKWELL INTERNATIONAL CORPORATION (US) | 1981-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030164286-A1 | Apparatus for decomposing halogenated aliphatic hydrocarbon compounds or aromatic compounds | AHR, ARNT, TRPA1 | CYP1A2 350/4885RXRA 3808/4885RXRB 3905/4885 |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | MCHR1, MCHR2, MC1R | CYP1A2 690/4885RXRA 1395/4885RXRB 1565/4885 |
| US-20020130030-A1 | METHOD OF DECOMPOSING HALOGENATED ALIPHATIC HYDROCARBON COMPOUNDS OR AROMATIC COMPOUNDS AND APPARATUS TO BE USED FOR THE SAME AS WELL AS METHOD OF CLARIFYING EXHAUST GAS AND APPARATUS TO BE USED FOR THE SAME | AHR, ARNT, TRPA1 | CYP1A2 213/4885RXRA 3177/4885RXRB 3103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.